Quantbot Technologies LP Increases Stake in U.S. Physical Therapy, Inc. (NYSE:USPH)

Quantbot Technologies LP raised its holdings in U.S. Physical Therapy, Inc. (NYSE:USPH) by 57.6% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 10,876 shares of the company’s stock after buying an additional 3,973 shares during the period. Quantbot Technologies LP owned approximately 0.07% of U.S. Physical Therapy worth $920,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the business. Vanguard Group Inc. boosted its holdings in U.S. Physical Therapy by 1.0% in the first quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock valued at $121,065,000 after purchasing an additional 10,175 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of U.S. Physical Therapy by 2.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after buying an additional 10,462 shares during the period. Envestnet Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 4.1% during the second quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock worth $22,179,000 after buying an additional 9,434 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of U.S. Physical Therapy by 3.4% during the second quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock worth $14,515,000 after buying an additional 5,111 shares during the period. Finally, Bahl & Gaynor Inc. raised its holdings in U.S. Physical Therapy by 1.5% in the second quarter. Bahl & Gaynor Inc. now owns 106,476 shares of the company’s stock valued at $9,841,000 after acquiring an additional 1,623 shares in the last quarter.

U.S. Physical Therapy Trading Up 1.7 %

Shares of U.S. Physical Therapy stock opened at $98.76 on Monday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. The company has a fifty day simple moving average of $86.60 and a 200-day simple moving average of $90.46. The stock has a market cap of $1.49 billion, a price-to-earnings ratio of 105.06, a PEG ratio of 4.47 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 15th will be issued a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Friday, November 15th. U.S. Physical Therapy’s payout ratio is 187.23%.

Insiders Place Their Bets

In other news, COO Graham D. Reeve sold 1,724 shares of the stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $96.29, for a total value of $166,003.96. Following the completion of the sale, the chief operating officer now directly owns 7,106 shares of the company’s stock, valued at approximately $684,236.74. This represents a 19.52 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Bernard A. Harris, Jr. sold 2,000 shares of the company’s stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total transaction of $185,900.00. Following the completion of the sale, the director now owns 16,726 shares of the company’s stock, valued at approximately $1,554,681.70. This trade represents a 10.68 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 6,896 shares of company stock valued at $656,940. 1.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research analysts have commented on the stock. Bank of America reiterated a “neutral” rating and set a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. Finally, Barrington Research reaffirmed an “outperform” rating and set a $108.00 price target on shares of U.S. Physical Therapy in a report on Thursday, November 21st.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.